Moderna Starts Human Trial of mRNA Vaccine Against Bundibugyo Ebola
4 days ago
In Breaking NewsClinical TrialsFeatured AnalysisInnovationTop Stories
China’s Biotech Model Is Moving From Asset Export to Integrated Drug Building
2 weeks ago
In AI & DataBiopharma ManufacturingFeatured AnalysisInnovationPartnershipsTop Stories
Bambusa’s Dual-Target Antibody Shows Early Atopic Dermatitis Activity After First Dose
2 weeks ago
In Breaking NewsClinical TrialsInnovationResearch Updates
IDEAYA Expands IDE892 Study in MTAP-Deleted Pancreatic and Lung Cancers
2 weeks ago
In Biopharma HighlightsClinical TrialsInnovationResearch Updates
MannKind Wins FDA Approval for Furoscix ReadyFlow, Cutting Heart Failure Diuretic Therapy From Five Hours to Ten Seconds
2 weeks ago
In Breaking NewsFDA ApprovalsInnovation
Celea Therapeutics Launches With $180 Million to Challenge Pirfenidone in IPF
1 month ago
In DealsFunding RoundsResearch UpdatesStartups
Slate Medicines Emerges With $130 Million to Chase PACAP, a Migraine Target Distinct From CGRP
1 month ago
In DealsFunding RoundsInnovationInvestments
FDA Extends Casgevy’s Reach to Children as Young as Two, Reshaping the Sickle Cell Treatment Landscape
1 month ago
In Breaking NewsFDA ApprovalsInnovationPharma Industry Updates
Australia’s TGA Grants Conditional Approval to Iovance’s Lifileucel — A First for T Cell Therapy in Solid Tumour Oncology
1 month ago
In BreakthroughsClinical TrialsFeatured AnalysisInnovation
Early Alzheimer’s Egg-Shell Protein Therapy Shows Promise in Small Human Study
11 months ago
In Clinical TrialsStartups
New Phase 1/2 Study Shows Promise for Oral Alzheimer’s Drug in Early Alzheimer’s Disease
1 year ago
In Breaking NewsBreakthroughsInnovationTop Stories
APG777 Shows Strong Skin Clearance in Phase 2 Trial for Moderate-to-Severe Atopic Dermatitis
1 year ago
In Clinical TrialsInnovationTop Stories
Biodexa Pharmaceuticals Reports Interim Results Highlighting Strategic Advances in Rare Disease Pipeline and Clinical Progress
1 year ago
In Clinical TrialsInnovationPharma Industry UpdatesResearch Updates
Atea Pharmaceuticals Advances Global Phase 3 HCV Program with First Patient Dosed in C-FORWARD Outside North America
1 year ago
In Clinical TrialsInnovationPartnershipsPharma Industry UpdatesResearch Updates
Hikma Pharmaceuticals Invests $1 Billion to Expand U.S. Generic Drug Manufacturing Capabilities and Announces Sustainability Goals
1 year ago
In Biopharma ManufacturingInnovationLeadersPharma Industry Updates
aTyr Pharma Added to Russell 2000® and Russell 3000® Indexes, Reflecting Growth and Market Confidence
1 year ago
In Biopharma HighlightsInnovationInvestmentsPeoplePharma Industry Updates
Oncolytics Biotech Highlights Growing Investor Interest as Global Oncology Drug Market Surpasses $900 Billion Forecast
1 year ago
In Biopharma HighlightsClinical TrialsInnovationInvestments
Viking Therapeutics Launches Phase 3 VANQUISH Program for VK2735 in Obesity and Type 2 Diabetes
1 year ago
In BreakthroughsClinical TrialsInnovationPharma Industry UpdatesResearch Updates
Metabolics Pharma Announces Positive Topline Results from Phase 1a Clinical Trial of ENT-03 in Obese and Diabetic Subjects
1 year ago
In BreakthroughsClinical TrialsInnovationPharma Industry UpdatesResearch Updates
MaaT Pharma Delivers Business Update Amid Positive Clinical and Commercial Milestones
1 year ago
In Biopharma HighlightsClinical TrialsInnovationPartnershipsPharma Industry Updates
CagriSema Demonstrates Significant Weight Loss in REDEFINE Clinical Trials, Offering New Hope for Obesity and Type 2 Diabetes Management
1 year ago
In BreakthroughsClinical TrialsInnovationPharma Industry UpdatesResearch Updates
Ocular Therapeutix Advances OTX-TKI Axitinib Hydrogel with Positive Phase 1/2 and Registrational Trial Data
1 year ago
In Biopharma ManufacturingClinical TrialsInnovationPharma Industry UpdatesTechnology
Zealand Pharma Reports Positive Phase 1b Results for Dual GLP-1/GLP-2 Agonist Dapiglutide in Obesity and Metabolic Disease
1 year ago
In Biopharma HighlightsBreakthroughsClinical TrialsInnovationResearch Updates
AbbVie Provides Update on VERONA Trial Evaluating Venetoclax in Newly Diagnosed Higher-Risk Myelodysplastic Syndromes
1 year ago
In Clinical TrialsInnovationPharma Industry UpdatesResearch Updates
CSL’s ANDEMBRY™ Gains FDA Approval as First Prophylactic Therapy Targeting Factor XIIa for Hereditary Angioedema
1 year ago
In Clinical TrialsFDA ApprovalsInnovationPharma Industry Updates
Clarity Pharmaceuticals Reports Positive Topline Phase II SABRE Trial Data for SAR-Bombesin Diagnostic in Breast Cancer
1 year ago
In Biopharma ManufacturingBreakthroughsClinical TrialsFDA ApprovalsIndustry ConferencesInnovationLeadersResearch UpdatesVenture Capital